Miriam Freimer

机构：The Ohio State University Wexner Medical Center, The Ohio State University · ORCID：0000-0001-8282-764X

发表论文 176 篇 · 总被引 6802 次 · h-index 38

代表论文

• Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy (2025 · JAMA Neurology · 被引 35)
• Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double‐blind, placebo‐controlled trial (2024 · Muscle & Nerve · 被引 16)
• An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1 (2026 · New England Journal of Medicine · 被引 11)
• Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis (2025 · Journal of Neurology · 被引 10)
• Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study (2025 · Therapeutic Advances in Neurological Disorders · 被引 8)
• Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS (2025 · Cardiology and Therapy · 被引 4)